McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is responding to the news release issued by the Apitipi Anicinapek Nation (“AAN”) dated February 12 th, 2025, that alleges McEwen has breached the Impact ...

KARACHI: IBA Karachi proudly hosted its Annual Career Fair 2025, organised by the IBA Career Development Center (IBA-CDC), at the IBA Main Campus. This year’s theme, “Think Next,” captured ...

A little more than two weeks into his second term, President Donald Trump’s approval rating stands at just under 50%, according to an average of national polls. FiveThirtyEight.com’s polling ...

AIM ImmunoTech (AIM) announced Safety Committee approval to proceed with the Phase 2 portion of the Phase 1b/2 clinical trial involving AIM’s Ampligen and AstraZeneca’s (AZN) anti-PD-L1 immune ...

Budget Session: Prime Minister Narendra Modi replies to the Motion of Thanks to the President’s address in the Lok Sabha during the Budget session of Parliament in New Delhi on Tuesday,(Sansad ...

OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. Emma Roth is a news writer ...

Several executive orders signed by President Donald Trump order a freeze of federal funds that Congress has already approved. But, according to both the Constitution and something called the ...

Copyright 2025 The Associated Press. All Rights Reserved. Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] LONDON (AP) — Thames Water, which ...

On Monday, three logos were revealed to the public, one for each potential nickname, but NHL fans weren't particularly impressed by the latest round of options. Much of the criticism was focused ...

Coinbase won approval from the United Kingdom’s Financial Conduct Authority (FCA) as a registered virtual asset service provider (VASP). The cryptocurrency exchange said in a Feb. 3 news ...

Need a break? Play the USA TODAY Daily Crossword Puzzle. It's not that aspirin is point-blank no longer recommended. But as medical professionals learn more about the potential benefits and ...

The U.S. Food and Drug Administration (FDA) created a major media stir last week when it announced the approval of suzetrigine (brand name Journavx), a unique new non-opioid, non-addictive drug for ...